M/s Vishat Diagnostic Pvt Ltd.
Risk-class mix (CDSCO)
| Class A (low risk) | Lowest-risk devices | 5 |
| Class B | Low–moderate risk | 704 |
| Class C | Moderate–high risk | 16 |
| Class D (high risk) | Highest-risk devices | 8 |
CDSCO device licences
Determination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyDetermination of specific IgE in human serumAllergens in liquid biotinylated form
IMP/IVD/2020/000017 · from ItalyGlobal footprint
Cross-railThe same manufacturer across regulators — 0 FDA clearances, 0 flagged adverse-event signals.
No FDA clearances linked — India-domestic footprint.
Sources: CDSCO (Central Drugs Standard Control Organisation) device licences · openFDA 510(k)/PMA · openFDA MAUDE · MedevIQ manufacturer-canonical. Registry data, AI-reviewed; expert sign-off in progress.